Invasive Cancer Incidence and Survival--United States, 2012

MMWR Morb Mortal Wkly Rep. 2015 Dec 18;64(49):1353-8. doi: 10.15585/mmwr.mm6449a1.

Abstract

Many factors contribute to changes in cancer incidence, including changes in risk exposures or changes in the use of cancer screening tests (1). To monitor changes in cancer incidence and assess progress toward achieving Healthy People 2020 objectives, CDC analyzed data from U.S. Cancer Statistics (USCS) for 2012, the most recent data available. USCS includes high quality incidence data from CDC's National Program of Cancer Registries (NPCR) and the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program, survival data from NPCR, and mortality data from the National Vital Statistics System (2). In 2012, a total of 1,529,078 invasive cancers were reported to cancer registries in the United States (excluding Nevada), for an annual incidence rate of 440 cases per 100,000 persons. Cancer incidence rates were higher among males (483) than females (412), highest among blacks (446), and ranged by state, from 371 to 515 per 100,000 persons (355 in Puerto Rico). The proportion of persons with cancer who survived ≥5 years after diagnosis was 66%. The proportion was the same for males and females (66%) but lower among blacks (60%) compared with whites (66%). These cancer incidence, survival, and mortality surveillance data are continually tracked and used by states to effectively plan health care allocation and support services.

MeSH terms

  • Adult
  • Age Distribution
  • Aged
  • Ethnicity / statistics & numerical data
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasms / epidemiology*
  • Neoplasms / ethnology
  • Neoplasms / mortality
  • Neoplasms / pathology*
  • Population Surveillance*
  • Registries
  • Residence Characteristics / statistics & numerical data
  • SEER Program
  • Sex Distribution
  • Survival Rate
  • United States / epidemiology
  • Young Adult